| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6099351 | Journal of Crohn's and Colitis | 2014 | 5 Pages |
Abstract
In patients with IBD receiving infliximab scheduled maintenance therapy, 1-hour infusion time for 10Â mg/kg infliximab seems to be well tolerated. This option might be considered in clinical practice in order to decrease the extra-burden of infliximab infusions in this patient population.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Abdenour Babouri, Xavier Roblin, Jérôme Filippi, Xavier Hébuterne, Marc-André Bigard, Laurent Peyrin-Biroulet,